Self-association of plasma membrane Ca2+-ATPase by volume exclusion
- Danuta Kosk-Kosicka(corresponding author),
- Maria M. Lopez,
- Ioulia Fomitcheva,
- Virgilio L. Lew
- Johns Hopkins University,
- University of Cambridge
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>At enzyme concentrations above 40 nM the configuration of the purified plasma membrane Ca<sup>2+</sup>-ATPase is that of calmodulin-insensitive dimers. Dilution of the enzyme generates progressively higher proportions of calmodulin-sensitive monomers with lower V<sub>max</sub> and Ca<sup>2+</sup> sensitivity than the dimeric enzyme. Dimerization from monomeric state had not been documented before. We investigated whether concentration by volume exclusion, obtained by addition of a large molecular weight dextran to a monomeric Ca<sup>2+</sup>-ATPase would elicit dimer-like behavior. Dextran induced self-association of monomers, as monitored by fluorescence energy transfer, but the Ca<sup>2+</sup> sensitivity of the re-associated monomers was lower than that of the native dimers. These results suggest that the self-association reaction is structurally but not functionally reversible, and also document the existence of a hitherto unknown kinetic state of the oligomerized Ca<sup>2+</sup>-ATPase, with high V<sub>max</sub> but low Ca<sup>2+</sup>-sensitivity.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 57-60 (4 pages)Journal (Volume, Issue Number)
FEBS Letters (Volume 371, Issue 1)Publication milestones
- Published - 08/28/1995
Publication status
Published - 08/28/1995
ISSN
0014-5793Publication IDs
- Scopus: 0029090297
- PubMed: 7545135
Publication metrics
Metrics
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
10
Captures
2
Funding Details
Acknowledgements. We thank Mrs. G. Roszczynska for her excellent technical assistance in the initial phase of the project. Supported by a Grant-in-Aid 92010190 from the American Heart Association (D.K.K.), by Grant GM 447130 from the National Institutes of Health (D.K.K.), and by The Wellcome Trust (V.L.L.).
FundersFunding number
WT
-NIH
-AHA
GM 447130
